Related Experiment Video
Updated: Jul 26, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Anticancer mechanisms on pyroptosis induced by Oridonin: New potential targeted therapeutic strategies
Guo Qiang Li1, Shi Xiang Gao1, Fu Han Wang1
1Pharmacy school, Dalian Medical University, Dalian 116044, Liaoning, PR China.
Abstract:
Pyroptosis is a type of inflammatory cell death that is triggered by the formation of pores on the cell membrane by gasdermin (GSDM) family proteins. This process activates inflammasomes and leads to the maturation and release of proinflammatory cytokines such as interleukin-1β (IL-1β) and interleukin-18 (IL-18). Pyroptosis, a form of programmed cell death, has been found to be associated with various biomolecules such as caspases, granzymes, non-coding RNA (lncRNA), reactive oxygen species (ROS), and NOD-like receptor protein 3 (NLRP3). These biomolecules have been shown to play a dual role in cancer by affecting cell proliferation, metastasis, and the tumor microenvironment (TME), resulting in both tumor promotion and anti-tumor effects. Recent studies have found that Oridonin (Ori) has anti-tumor effects by regulating pyroptosis through various pathways. Ori can inhibit pyroptosis by inhibiting caspase-1, which is responsible for activating pyroptosis of the canonical pathway. Additionally, Ori can inhibit pyroptosis by inhibiting NLRP3, which is responsible for activating pyroptosis of the noncanonical pathway. Interestingly, Ori can also activate pyroptosis by activating caspase-3 and caspase-8, which are responsible for activating pyroptosis of the emerging pathway; Ori has been found to be effective in inhibiting pyroptosis by blocking the action of perforin, which is responsible for facilitating the entry of granzyme into cells and activating pyroptosis. Additionally, Ori plays a crucial role in regulating pyroptosis by promoting the accumulation of ROS while inhibiting the ncRNA and NLRP3 pathways. It is worth noting that all of these pathways ultimately regulate pyroptosis by influencing the cleavage of GSDM, which is a key factor in the process. These studies concludes that Ori has extensive anti-cancer effects that are related to its potential regulatory function on pyroptosis. The paper summarizes several potential ways in which Ori participates in the regulation of pyroptosis, providing a reference for further study on the relationship between Ori, pyroptosis, and cancer.
Insights
Oridonin (Ori) exhibits anti-cancer effects by modulating pyroptosis, a key inflammatory cell death pathway. Ori regulates pyroptosis through various mechanisms, impacting tumor growth and the tumor microenvironment.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Pyroptosis is an inflammatory cell death pathway involving gasdermin (GSDM) pore formation, inflammasome activation, and release of cytokines like IL-1β and IL-18.
- Biomolecules such as caspases, granzymes, non-coding RNA (lncRNA), reactive oxygen species (ROS), and NLRP3 are implicated in pyroptosis and exhibit dual roles in cancer progression and suppression.
- The tumor microenvironment (TME) is significantly influenced by pyroptosis, affecting tumor proliferation, metastasis, and overall anti-tumor immunity.
Purpose of the Study:
- To investigate the anti-tumor effects of Oridonin (Ori) through its regulation of pyroptosis.
- To elucidate the diverse molecular pathways by which Ori modulates pyroptosis.
- To provide a comprehensive overview of Ori's role in pyroptosis for future cancer research.
Main Methods:
- Review of existing literature on Oridonin, pyroptosis, and cancer.
- Analysis of Ori's interactions with key pyroptosis regulators including caspases, NLRP3, perforin, ROS, and lncRNA.
- Examination of Ori's impact on GSDM cleavage, the central event in pyroptosis.
Main Results:
- Oridonin (Ori) demonstrates anti-cancer properties by modulating pyroptosis via multiple pathways.
- Ori can inhibit pyroptosis by targeting caspase-1 (canonical pathway) and NLRP3 (noncanonical pathway).
- Ori can also activate pyroptosis through caspase-3 and caspase-8 (emerging pathway) and by promoting ROS accumulation, while inhibiting ncRNA and NLRP3 pathways.
Conclusions:
- Oridonin (Ori) possesses extensive anti-cancer effects linked to its regulatory role in pyroptosis.
- Ori's modulation of pyroptosis involves intricate interactions with various signaling molecules and pathways, ultimately influencing GSDM cleavage.
- Understanding Ori's multifaceted regulation of pyroptosis offers a promising avenue for developing novel cancer therapies.
More Related Videos
06:12Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
11:00Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...